PhD student Hannah Lenkowski helped launch the ChemE-Sports team at the University of Tennessee when she arrived on campus in 2023 to begin her studies.

Molecular biologists don’t usually enter engineering programs—except for Desirée Denman, who’s applying her experience to Paul Dalhaimer’s inflammation research.

When a widely accepted theory couldn’t explain the data, Dalhaimer’s lab looked deeper—and revealed new possibilities for nanoparticle medicine.

UT CBE alumnus Monireh Asoudeh (’22) shares her college experience, as well as her job as a research scientist at Stanford University’s School of Medicine.

SR-BI, the receptor for high-density lipoprotein (HDL; “good cholesterol”) is one of the most sought after targets for treating metabolic […]

Eukaryotic cells store cholesterol/sterol esters (SEs) and triacylglycerols (TAGs) in lipid droplets, which form from the contiguous endoplasmic reticulum (ER) […]

Associate Professor Paul Dalhaimer is researching the molecular mechanisms governing the onsets of obesity and type 2 diabetes.